Felipe H Valle, Shaun G Goodman, Mary Tan, Andrew Ha, Samer Mansour, Robert C Welsh, Andrew T Yan, Kevin R Bainey, Stephane Rinfret, Brian J Potter, Razi Khan, Gerald Simkus, Madhu K Natarajan, J D Schwalm, Benoit Daneault, Mark J Eisenberg, Joseph Abunassar, Bryan Har, Jean Gregoire, Jean-Francois Tanguay, Christopher B Overgaard, Jean-Pierre Dery, Robert De Larochelliere, Jean-Michel Paradis, Mina Madan, Basem Elbarouni, Derek Y F So, Ata-Ur-Rehman Quraishi, Akshay Bagai
BACKGROUND: In patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI), selecting an antithrombotic regimen requires balancing risks of ischemic cardiac events, stroke, and bleeding. METHODS: We studied 467 patients with AF undergoing PCI in the time period from December 2015 to July 2018 identified via a chart audit by 47 Canadian cardiologists in the CONNECT AF+PCI (the Co ordinated N ational N etwork to E ngage Interventional C ardiologists in the Antithrombotic T reatment of Patients With A trial F ibrillation Undergoing P ercutaneous C oronary I ntervention) study, to determine patterns of initial antithrombotic therapy selection...
December 2021: CJC open